All Stories

  1. Sofosbuvir, pegylated interferon and ribavirin in treatment of an Egyptian cohort with hepatitis C virus infection in real life clinical practice.

    Article • Infectious Disorders - Drug Targets, September 2018, Bentham Science Publishers

    sherief Abd-Elsalam, Amal Selim, Rehab Badawi, Abdelrahman Kobtan, Associate Professor Sally Elnawasany

  2. Predicting esophageal varices in cirrhotic hepatitis C virus patients using noninvasive measurement of insulin resistance variables

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, August 2018, Bentham Science Publishers

    Rehab Badawi, sherief Abd-Elsalam, Associate Professor Sally Elnawasany